1.Scrip code : 532523
Name : Biocon Ltd.
Subject : Biocon”s Oral Solid Dosage Manufacturing Facility Completes Pre-Approval U.S. FDA Inspection With Zero Observations.
This is to inform you that the U.S. Food and Drug Administration (FDA) conducted a Pre-Approval Inspection (PAI) of the Oral Solid Dosage Manufacturing Facility of Biocon Pharma Ltd, a subsidiary of Biocon Ltd, which was triggered by the submission of an Abbreviated New Drug Application (ANDA). The inspection of the Bengaluru facility, which took place between January 13 and January 17, 2020, concluded with zero observations and no Form 483 was issued. We remain committed to global standards of Quality and Compliance.” – Company Spokesperson Kindly take the same on record and acknowledge.
2.Scrip code : 542399
Name : Chalet Hotels Limited
Subject : Announcement under Regulation 30 (LODR)-Acquisition
We wish to inform you that the Board of Directors of the Company has at its meeting held today i.e. January 17, 2020 approved the execution of a Share Purchase Agreement for acquisition of 100% of the Equity Shares and Zero Coupon, Fully Compulsorily Convertible Debentures of Belaire Hotels Private Limited (BHPL) and Seapearl Hotels Private Limited (SHPL), subject to conditions precedent. The Company has post the Board Meeting executed a Share Purchase Agreement of even date for the acquisition. The details as required under Regulation 30 of the SEBI LODR Regulations read with SEBI Circular CIR/CFD/CMD/4/2015 dated September 9, 2015 are given in Annexure A to this letter. You are requested to take the same on record.
3.Scrip code : 540953
Name : Kenvi Jewels Limited
Subject : Corporate Action- Fixed Record Date For Bonus Issue
With reference to the captioned subject and pursuant to SEBI LODR and applicable statutory provisions, this is to inform you that the record date shall be 30.01.2020 to determine the name of shareholders entitled for Bonus equity shares in proportion of 115 (One Hundred Fifteen) bonus equity share for every 100 (hundred) fully paid-up equity share held.
4.Scrip code : 539287
Name : Ortin Laboratories Limited
Subject : Amendment In The Appointed Date From 01.04.2017 To 01.04.2020
In The Scheme Of Arrangement Amendment in the appointed date from 01.04.2017 to 01.04.2020 in the scheme of arrangement between Ortin Laboratories Limited (Demerged Company) and Vineet Laboratories Limited (Resulting Company)
5.Scrip code : 533274
Name : Prestige Estates Projects Limited
Subject : Prestige Estates Subsidiary Has Acquired 50% Stake In Lokhandwala DB Realty LLP
M/s. Prestige Falcon Realty Ventures Private Limited (‘PFRVPL’),wholly owned subsidiary of M/s. Prestige Estates Projects Limited, has invested in Lokhandwala DB Realty LLP (‘LLP’) by way of capital account contribution and admitted as partner of the LLP with 50% economic and voting rights.